| April 27, 2009 | News for the transfusion medicine and cellular therapy community |
 |  |
-
Vaccine makers ready to aid health authorities in combating swine flu: Roche Holding, Sanofi Pasteur and other drug manufacturers said they are prepared to supply the World Health Organization and other health authorities with influenza vaccine in the event of a swine flu pandemic. The companies also said they are ready to start development of a new vaccine against the swine flu virus strain, which appears vulnerable to Roche's Tamiflu and GlaxoSmithKline's Relenza. Reuters
(4/26)
 |
|  |
| | Gain Efficiency in Processing
Being responsive to changing customer needs is essential to good business. With the Leukotrap® RC PL System, you can collect all your WB donations into one collection system and produce three leukoreduced components - RBC, platelets and plasma. Learn more. | |
 |
ADVERTISEMENT |
|  |
| Science & Health |  |  |
|
- Study finds differences in performance of malaria rapid tests
A study co-sponsored by the World Health Organization evaluated the performance of dozens of commercially available rapid diagnostic tests for malaria. The study found that some tests performed well in tropical temperatures and were able to identify low parasite densities in blood samples, and others were able to pinpoint the parasite at only high densities. "This is an important first step in establishing a broader system of diagnostics surveillance and quality assurance to ensure sound and accurate diagnosis of malaria in poor and remote settings," an expert said. New Kerala (India)/Asian News International
(4/24)
       
 |
|  |
| | Unlock the Power of Your Database
Join faculty on May 6 for the audioconference Turning Data into Knowledge to learn ways to make the most of data you already have. You'll also learn ways to assess and improve the quality of your data while avoiding pitfalls in analysis. To register for this and other AABB audioconferences, click here. | |
 |
ADVERTISEMENT |
|  |
Top five news stories selected by AABB SmartBrief readers in the past week.
- Results based on number of times each story was clicked by readers.
 |
|  |
| | Can Typenex Embody Your Process?
The answer is yes! Typenex blood band solutions can embody your unique transfusion process. From barcode stickers that remain on the patient, to a specimen sticker with directions for use Typenex can enable your culture of safety. See if the Next Generation Barcode Blood Band is the right fit for your fantastic facility. | |
 |
ADVERTISEMENT |
|  |
| Emerging Trends |  |  |
|
- Report advises hospitals to reconsider EHR priorities
A Computer Sciences Corp. report recommends that hospitals put more emphasis on physician documentation and electronic problem lists when implementing electronic health records. The Virginia-based consulting firm said this "would provide a more complete information base for concurrent quality management." Health Data Management
(4/24)
       
| Industry News & Practice |  |  |
|
- Immucor feels effect of antitrust investigation
Immucor, a manufacturer of blood-screening products, saw its stock decrease 27% -- its biggest drop since 1987 -- after being subpoenaed by the Justice Department in connection with its investigation into "possible violations of the federal criminal antitrust laws in the blood reagents industry." The company also is the subject of an investigation launched in 2007 by the Federal Trade Commission for possibly engaging in unfair marketing methods. Bloomberg
(4/24)
       
- Vertex says combo of Roche drugs, telaprevir shows promise in study
Vertex Pharmaceuticals announced that the combination of its hepatitis C drug telaprevir with Roche Holding's Pegasys and Copegus eradicated signs of the virus and elicited sustained response in 52% of patients, compared with 14% of those who received Roche's medicines alone. The yearlong study observed 453 patients who either relapsed after or failed to respond to previous hepatitis C therapies. Bloomberg
(4/25)
       
 |
|  |
 | The Buzz(CORPORATE ANNOUNCEMENTS)
Iowa Blood Improves Efficiency and Blood Quality by: Automating document control for SOPs, flow charts, and floor plans
Helping company expand without additional overhead
Improving compliance with 21 CFR Part 606 and 21 CFR Part 11 DOWNLOAD CASE STUDY NOW
|  |
 |
|  |
| Government & Regulatory |  |  |
|
- Obama administration seeks ways to address doctor shortage
White House officials are trying to address the shortage of general practitioners in the nation by introducing a number of proposals, including boosting Medicare payments to primary care providers. Meanwhile, specialists are calling on Congress to find ways to raise additional funding to support primary care without redistributing the money among physicians. The New York Times
(4/26)
       
| Association News |  |  |
|
-
Summary of BPAC meeting highlights discussions on Chagas' disease, hepatitis B NAT screening, plasma for further manufacture
A summary of the recent meeting of the FDA's Blood Products Advisory Committee highlights presentations and debates about selective strategies to test blood donors for Trypanosoma cruzi, the agent of Chagas' disease; testing blood and HCT/P donors for hepatitis B virus infection using nucleic acid testing; and FDA's current considerations on plasma obtained from a whole blood donor for further manufacturing use. Read the summary.        
| SmartQuote |  |  |
|
 | The way to get good ideas is to get lots of ideas, and throw the bad ones away."
|
| |
| Advertise |
|
Corporate Relations Manager:
Tamara Zein +1-240-333-6604
|
|
|
| |
|
Read more at SmartBrief.com |
|
A powerful Web site for SmartBrief readers including:
|
|
|
|
| |
| |
| | Recent AABB SmartBrief Issues:
- Friday, April 24, 2009
- Thursday, April 23, 2009
- Wednesday, April 22, 2009
- Tuesday, April 21, 2009
- Monday, April 20, 2009
| | | AABB Managing Editor:
Naomi Greer
Lead Editor: Ashley McMaster
Mailing Address:
SmartBrief, Inc.®, 1100 H ST NW, Suite 1000, Washington, DC 20005 | |
| |
|
| © 1999-2010 SmartBrief, Inc.® Legal Information |
|